Impact BioMedical Inc.

1.60
-0.68 (-29.82%)
At close: Mar 28, 2025, 3:59 PM
1.59
-0.59%
After-hours: Mar 28, 2025, 06:58 PM EDT

Impact BioMedical Ratios Statement

Year FY22 FY21 FY20 FY19 FY18 FY17
PE Ratio -0.62 -5.18 -16 -17 -4.25 n/a
PEG Ratio -0.01 -0.02 n/a 0.23 n/a n/a
PS Ratio 6.07 n/a n/a n/a n/a n/a
PB Ratio 1.65 6.80 19.95 8.46 5.88 n/a
P/FCF Ratio -1.47 -6.16 -15.33 -23.17 -5.42 n/a
P/OCF Ratio -1.5 -6.16 -15.52 -23.17 -5.42 n/a
OCF/S Ratio -4.05 n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.44 0.14 n/a n/a n/a n/a
Quick Ratio 1.60 0.91 5.31 10.81 12.61 72.43
Current Ratio 1.60 0.91 5.31 10.81 12.61 72.43
Asset Turnover 0.17 n/a n/a n/a n/a n/a
Interest Coverage 7.34 -255.45 n/a n/a n/a n/a
Return on Equity (ROE) -2.66 -1.31 -1.25 -0.5 -1.38 n/a
Return on Assets (ROA) -1.66 -0.97 -1.01 -0.45 -1.27 n/a
Return on Capital (ROIC) 0.09 -1.28 0.00 -0.17 0.22 n/a
Dividend Yield n/a 0.02 n/a n/a n/a n/a
Payout Ratio n/a -0.11 n/a n/a n/a n/a
Gross Profit Margin 1.00% n/a n/a n/a n/a n/a
Net Profit Margin -9.8% n/a n/a n/a n/a n/a
Pretax Profit Margin -9.8% n/a n/a n/a n/a n/a
Operating Profit Margin 0.46% n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a